Bnp Paribas Asset Management Holding S.A. Moderna, Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $40.4 Billion
- Q3 2024
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Moderna, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 85,473 shares of MRNA stock, worth $2.79 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
85,473
Previous 56,296
51.83%
Holding current value
$2.79 Million
Previous $6.69 Million
14.55%
% of portfolio
0.01%
Previous 0.02%
Shares
18 transactions
Others Institutions Holding MRNA
# of Institutions
909Shares Held
235MCall Options Held
10.6MPut Options Held
18.6M-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.31 Billion0.05% of portfolio
-
Baillie Gifford & CO38.9MShares$1.27 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$833 Million0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$549 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$236 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $12.8B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...